Two directors to leave Abcam
Mr. Martin has more than 25 years’ experience in the life science industry within the UK and US, in both executive and non-executive roles.
Mr. Martin was most recently non-executive chairman of Immunodiagnostics Systems Holdings plc and Sphere Medical Holding plc.
His prior executive appointments include chief executive officer of British Bio-Technology Products, AZUR Environmental, Molecular Probes Inc, Celsis International plc and president of Invitrogen Corporation.
Mr. Martin’s previous non-executive appointments include Prelude Trust plc, NeuTec Pharma plc and Molecular Insight Pharmaceuticals. He has also served on the main board of Invitrogen Corporation and the strategic advisory board of Agilent Technologies.
Mr. Martin is currently non-executive chairman of PhicoTherapeutics Ltd and non-executive director of Orthofix International N.V. He is a fellow of the Royal Society of Medicine.
Mr. Ross is an eCommerce executive and advisor with a high level of technical expertise. After working at McKinsey & Company from 1994 to 1999, he co-founded the online retailer figleaves.com in 1999, where he was chief executive officer.
In 2006, Mr. Ross co-founded DynamicAction (previously eCommera), an eCommerce technology and advisory business where he is currently chief scientist.
Mr. Ross is an executive director of DynamicAction and a non-executive director of Sainsbury’s Bank and Wex Photographic. ■
What to read next
LATEST MOVES FROM United Kingdom
- Mallinckrodt Pharmaceuticals elects David Norton to board
- John Lewis Partnership appoints Laura Wade-Gery as director
- 40% of senior executives to leave Reckitt Benckiser
- Oxford Immunotec Global appoints Stefan Linn as COO
- Terra Firma Capital appoints Jerry Patava to board
More inside POST